Clinical Trials Sponsored by Peregrine Ophthalmic

Total 251 results

Peregrine Ophthalmic

Recruiting

Assess the Safety, Tolerability and Efficacy of Latanoprost Liposome for Lower Eyelid Steatoblepharon

Lower Eyelid Steatoblepharon

United States
Peregrine Ophthalmic

Completed

Open Label Extension of LipoLat-CS202

Glaucoma

United States
Peregrine Ophthalmic

Completed

POLAT-001 Compared to Latanoprost Ophthalmic Solution in Patients With Ocular Hypertension and Open-angle Glaucoma

Glaucoma

United States
Peregrine Pharmaceuticals

Terminated

Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors

Malignant Solid Tumor

United States
Peregrine Pharmaceuticals

Completed

Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung Cancer (SUNRISE)

Carcinoma, Non-Small-Cell Lung | Non-Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Non-Small-Cell Lung Carcinoma | Non-Small-Cell Lung Cancer Stage IIIB | Non-Small-Cell Lung Cancer Stage IV | Non-Small-Cell Lung Cancer Metastatic

United States, Australia, Belgium, France, Germany, Greece, Hungary, Italy, Korea, Republic of, Romania, Russian Federation, Spain, Taiwan, Ukraine
Peregrine Pharmaceuticals

Completed

A Safety and Efficacy Study of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer

Breast Cancer

Georgia
Peregrine Pharmaceuticals

Completed

Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer

Non-Squamous Non-Small Cell Lung Cancer

United States, India, Georgia, Russian Federation, Ukraine
Peregrine Pharmaceuticals

Completed

Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer

Non-small-cell Lung Cancer

United States, India, Georgia, Russian Federation, Ukraine
Peregrine Pharmaceuticals

Completed

Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse

Glioblastoma Multiforme

United States, India
Peregrine Pharmaceuticals

Completed

Repeat-Dose Study of Bavituximab in Patients With Chronic Hepatitis C

Hepatitis C

United States
Peregrine Pharmaceuticals

Withdrawn

Phase 2 Trial of Durvalumab With or Without Bavituximab in Patients With Previously Treated Metastatic Non-small-cell Lung Cancer

Non-Small Cell Lung Cancer
Peregrine Pharmaceuticals

Completed

Pilot Trial of Bavituximab Combined With Ribavirin for Initial Treatment of Chronic HepC Virus Genotype 1 Infection

Hepatitis C

Georgia
Peregrine Pharmaceuticals

Completed

Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme

Recurrent Glioblastoma Multiforme

United States
Peregrine Pharmaceuticals

Completed

Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

India
Peregrine Pharmaceuticals

Completed

Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer

Carcinoma Breast Stage IV

India
Peregrine Pharmaceuticals

Completed

Study of Bavituximab in Patients With Chronic Hepatitis C Virus Infection

Hepatitis C

United States
Peregrine Pharmaceuticals

Withdrawn

Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Peregrine Pharmaceuticals

Completed

Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer

Metastatic Pancreatic Cancer

United States, Ukraine
Peregrine Pharmaceuticals

Withdrawn

A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer

Breast Cancer | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | Triple-Negative Breast Cancer | Triple-Negative Breast Neoplasm | ER-Negative PR-Negative HER2-Negative Breast Neoplasms | ER-Negative PR-Negative HER2-Negative Breast Cancer
Peregrine Pharmaceuticals

Completed

Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus

Hepatitis C Virus | Hiv Infections

United States
Peregrine Pharmaceuticals

Completed

Study of Bavituximab in Patients With Advanced Solid Tumor Malignancies

Tumors

United States
Jerini Ophthalmic

Completed

A Phase 1 Safety Study of Single and Repeated Doses of JSM6427 (Intravitreal Injection) to Treat AMD

Macular Degeneration

United States
Peregrine Eye and Laser Institute

Completed

Postoperative Safety Outcomes of Intraoperative Intracameral Preservative-Free Moxifloxacin Versus Levofloxacin

Cataract Senile | Endophthalmitis | Antibiotic Side Effect | Safety Issues

Philippines
Peregrine Eye and Laser Institute

Completed

Time Efficiency Comparison of Two IntraVitreal Injection Techniques (TIVI)

Diabetic Macular Edema | Choroidal Neovascularization | Neovascular Age-related Macular Degeneration | Uveitic Macular Edema | Retinal Vein Occlusion With Macular Edema

Philippines
Advanced Ophthalmic Pharma

Completed

Bioequivalence of Eye Drops and Spray Administration of Vigamox

Cataract

Israel
Peregrine Pharmaceuticals

Completed

Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma

Brain and Central Nervous System Tumors

United States
Advanced Ophthalmic Pharma

Withdrawn

Using Device Delivering Ophthalmic Solution in a Spray Form Instead of Eye Drops

Cataract
Omega Ophthalmics

Active, not recruiting

Clinical Investigation of Omega Refractive Capsule, Model VI (ORCVI)

Cataract

Costa Rica
Omega Ophthalmics

Completed

Comparison of Gemini III Rev 2 Implanted in Conjunction With an Approved IOL vs Eyes Implanted With an Approved IOL

Cataract

Costa Rica
Omega Ophthalmics

Completed

Clinical Investigation of Omega Refractive Capsule Model V With Use of an FDA Approved IOL (ORCV)

Cataract

Costa Rica
Omega Ophthalmics

Completed

Clinical Investigation of OMEGA Gemini Capsule, Model Gemini IV With an Approved Monofocal or Toric IOL

Cataract

Costa Rica
Medical University of South Carolina
Peregrine Pharmaceuticals

Terminated

Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer

Prostatic Neoplasms | Prostate Cancer

United States
Peregrine Eye and Laser Institute
Alcon Research

Recruiting

Pars Plana Vitrectomy With 25-gauge 20000 Cpm, Bevel-tip Cutter (HYPE)

Vitreous Hemorrhage | Retinal Detachment | Epiretinal Membrane | Vitrectomy | Macular Holes | Dislocated Intraocular Lens Into Vitreous | Retained Lens Fragments

Philippines
UNC Lineberger Comprehensive Cancer Center
Peregrine Pharmaceuticals

Completed

Bavituximab Plus Carbo and Pemetrexed in Chemo-Naive Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Subjects

Non Small Cell Lung Cancer (NSCLC)

United States
Ziemer Ophthalmic Systems AG

Recruiting

FLACS in Pediatric Patients Using FEMTO LDV-Z8

Cataract in Child

Belgium
Ziemer Ophthalmic Systems AG

Recruiting

Comparison of Femto-laser and Manually Created Clear Corneal Incisions During Cataract Surgery (Z8_CCI)

Cataract

Switzerland
Fatebenefratelli and Ophthalmic Hospital

Completed

The All-comers Sirolimus-coated Balloon European Registry (EASTBOURNE)

Percutaneous Coronary Intervention | Angioplasty, Balloon, Coronary | Arteriosclerosis, Coronary | Coronary Angioplasty, Transluminal Balloon

Italy
Ziemer Ophthalmic Systems AG

Completed

Safety and Efficacy of FLACS With the FEMTO LDV Z8 Laser Compared to Conventional Cataract Surgery in Chinese Patients (Z8CAT01)

Cataract

Switzerland
Ziemer Ophthalmic Systems AG

Completed

A Comparison of Two Devices for Taking Measurements of the Eye to Assist in Lens Selection for Cataract Surgery

Cataract

Switzerland
Ziemer Ophthalmic Systems AG

Not yet recruiting

CLEAR Procedure in Myopia and Astigmatism - Registry Study

Astigmatism | Myopia
Implandata Ophthalmic Products GmbH

Completed

Long-term Safety and Performance of the ARGOS-IO Intraocular Pressure Sensor System in Subjects With Primary Open Angle Glaucoma (POAG)

Primary Open-angle Glaucoma

Germany
Ziemer Ophthalmic Systems AG

Completed

Galilei Lens Professional vs. Predicate Devices: a Comparison Study

Cataract

Switzerland
Fatebenefratelli and Ophthalmic Hospital

Completed

Drug Eluting Balloon Efficacy for Small Coronary Vessel Disease Treatment (PICCOLETO II)

Cardiovascular Diseases
Ophthalmic Consultants of Boston

Completed

YAG Vitreolysis for Floaters

Posterior Vitreous Detachment | Weiss Ring | Floaters
Ziemer Ophthalmic Systems AG

Recruiting

LASIK Surgery With a New Laser for the Treatment of Myopia Without Astigmatism (AQUARIUZ2020)

Astigmatism | Myopia

Switzerland
Ziemer Ophthalmic Systems AG

Completed

Cataract Surgery: Femto LDV Z8 Versus Conventional (COMFORT)

Cataract
Implandata Ophthalmic Products GmbH

Completed

Safety and Performance Study of the ARGOS-IO (Intraocular) System in Patients With Primary Open Angle Glaucoma (POAG)

Primary Open Angle Glaucoma (POAG)

Germany
Implandata Ophthalmic Products GmbH

Completed

Safety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis Implantation

Congenital Glaucoma | Stevens-Johnson Syndrome | Graft vs Host Disease | Congenital Aniridia | Chemical Burns

Germany
Ophthalmic Consultants of Connecticut

Unknown

Patient Satisfaction and Tear Osmolarity With the Use of Blink Tears, Blink Gel Tears and Systane Balance

Dry Eye

United States
Ophthalmic PDT Study Group

Completed

PDT Study for Exudative AMD With PCV

Age Related Macular Degeneration

Japan

Clinical Trials Sponsored by Peregrine Ophthalmic

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations